36
Participants
Start Date
October 15, 2020
Primary Completion Date
February 28, 2025
Study Completion Date
June 30, 2025
Cohort 1, GNR-084
0.01 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles
Cohort 2, GNR-084
0.1 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles
Cohort 3, GNR-084
1 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles
Cohort 4, GNR-084
4 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles
Cohort 5, GNR-084
10 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles
Cohort 6, GNR-084
20 ng/kg 6-hours intravenous infusion once a week; 4 doses per cycle, up to 5 cycles
RECRUITING
Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia), Moscow
RECRUITING
Almazov National Medical Research Centre, Saint Petersburg
RECRUITING
Pavlov First Saint Petersburg State Medical University, Saint Petersburg
AO GENERIUM
INDUSTRY